Tuesday, November 11, 2008
In a stunning decision last Friday, the California First District Court of Appeal held that drug manufacturers could be held liable for harm caused by a competitor's generic version of the same drug. In its opinion (pdf), the court wrote: "Wyeth owes a duty of care to those people it should reasonably foresee are likely to ingest metoclopramide in either the name-brand or generic versions when it is prescribed by their physicians in reliance on Wyeth's representations."
As the Beck & Herrmann opine, the decision "effectively stands product liability law on its head." More on the decision from The Recorder/law.com and Pharmalot. Bob Egelko also has a report in the San Fran Chronicle.